BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 16084660)

  • 1. Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats.
    Lane DA; Patel PA; Morgan MM
    Neuroscience; 2005; 135(1):227-34. PubMed ID: 16084660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential susceptibility of the PAG and RVM to tolerance to the antinociceptive effect of morphine in the rat.
    Morgan MM; Clayton CC; Boyer-Quick JS
    Pain; 2005 Jan; 113(1-2):91-8. PubMed ID: 15621368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and electrophysiological evidence for tolerance to continuous morphine administration into the ventrolateral periaqueductal gray.
    Lane DA; Tortorici V; Morgan MM
    Neuroscience; 2004; 125(1):63-9. PubMed ID: 15051146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive tolerance to morphine from repeated nociceptive testing in the rat.
    Lane DA; Morgan MM
    Brain Res; 2005 Jun; 1047(1):65-71. PubMed ID: 15878767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent dosing prolongs tolerance to the antinociceptive effect of morphine microinjection into the periaqueductal gray.
    Morgan MM; Tierney BW; Ingram SL
    Brain Res; 2005 Oct; 1059(2):173-8. PubMed ID: 16182261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral evidence linking opioid-sensitive GABAergic neurons in the ventrolateral periaqueductal gray to morphine tolerance.
    Morgan MM; Clayton CC; Lane DA
    Neuroscience; 2003; 118(1):227-32. PubMed ID: 12676152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous opioids acting at a medullary mu-opioid receptor contribute to the behavioral antinociception produced by GABA antagonism in the midbrain periaqueductal gray.
    Roychowdhury SM; Fields HL
    Neuroscience; 1996 Oct; 74(3):863-72. PubMed ID: 8884782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive tolerance revealed by cumulative intracranial microinjections of morphine into the periaqueductal gray in the rat.
    Morgan MM; Fossum EN; Levine CS; Ingram SL
    Pharmacol Biochem Behav; 2006 Sep; 85(1):214-9. PubMed ID: 16979226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance to non-opioid analgesics in PAG involves unresponsiveness of medullary pain-modulating neurons in male rats.
    Tortorici V; Aponte Y; Acevedo H; Nogueira L; Vanegas H
    Eur J Neurosci; 2009 Mar; 29(6):1188-96. PubMed ID: 19302154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential development of antinociceptive tolerance to morphine and fentanyl is not linked to efficacy in the ventrolateral periaqueductal gray of the rat.
    Bobeck EN; Haseman RA; Hong D; Ingram SL; Morgan MM
    J Pain; 2012 Aug; 13(8):799-807. PubMed ID: 22766006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defensive behaviors evoked from the ventrolateral periaqueductal gray of the rat: comparison of opioid and GABA disinhibition.
    Morgan MM; Clayton CC
    Behav Brain Res; 2005 Oct; 164(1):61-6. PubMed ID: 16029902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance P microinjected into the periaqueductal gray matter induces antinociception and is released following morphine administration.
    Rosén A; Zhang YX; Lund I; Lundeberg T; Yu LC
    Brain Res; 2004 Mar; 1001(1-2):87-94. PubMed ID: 14972657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative contribution of the dorsal raphe nucleus and ventrolateral periaqueductal gray to morphine antinociception and tolerance in the rat.
    Campion KN; Saville KA; Morgan MM
    Eur J Neurosci; 2016 Nov; 44(9):2667-2672. PubMed ID: 27564986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrus phase differences in female rats in morphine antinociception elicited from the ventrolateral periaqueductal gray.
    Shane R; Bernal SY; Rozengurtel S; Bodnar RJ
    Int J Neurosci; 2007 Jun; 117(6):811-22. PubMed ID: 17454245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of cholecystokinin in the opioid tolerance induced by dipyrone (metamizol) microinjections into the periaqueductal gray matter of rats.
    Tortorici V; Nogueira L; Aponte Y; Vanegas H
    Pain; 2004 Nov; 112(1-2):113-20. PubMed ID: 15494191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABAergic and glutamatergic afferents in the dorsal raphe nucleus mediate morphine-induced increases in serotonin efflux in the rat central nervous system.
    Tao R; Auerbach SB
    J Pharmacol Exp Ther; 2002 Nov; 303(2):704-10. PubMed ID: 12388654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of GABAergic modulation of the nucleus submedius (Sm) morphine-induced antinociception.
    Jia H; Xie YF; Xiao DQ; Tang JS
    Pain; 2004 Mar; 108(1-2):28-35. PubMed ID: 15109504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lesions of the periaqueductal gray disrupt input to the rostral ventromedial medulla following microinjections of morphine into the medial or basolateral nuclei of the amygdala.
    McGaraughty S; Farr DA; Heinricher MM
    Brain Res; 2004 May; 1009(1-2):223-7. PubMed ID: 15120601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioidergic and GABAergic mechanisms in the rostral ventromedial medulla modulate the nociceptive response of vocalization in guinea pigs.
    da Silva LF; Coutinho MR; Menescal-de-Oliveira L
    Brain Res Bull; 2010 May; 82(3-4):177-83. PubMed ID: 20385207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-periaqueductal grey microinjections of an imidazo[1,2-b]pyridazine derivative, DM2, affects rostral ventromedial medulla cell activity and shows antinociceptive effect.
    Palazzo E; Rimoli MG; De Chiaro M; Guida F; Melisi D; Curcio A; de Novellis V; Marabese I; Rossi F; Abignente E; Maione S
    Neuropharmacology; 2010 Mar; 58(3):660-7. PubMed ID: 19944111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.